TB treatment: as simple as DOT?

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Clinical Trial Methodology

Background:

• Tuberculosis (TB) treatment completion remains a significant global health challenge.
• Directly Observed Therapy (DOT) has been widely promoted as a key strategy for improving TB treatment adherence since 1993.
• The effectiveness of DOT in ensuring treatment completion is a subject of ongoing research and debate.

Purpose of the Study:

• To evaluate the impact of Directly Observed Therapy (DOT) on tuberculosis (TB) treatment completion rates.
• To analyze the methodologies and findings of randomized controlled studies assessing DOT effectiveness.
• To identify factors contributing to the challenges in TB treatment completion.

Main Methods:

• Review and analysis of three randomized controlled studies conducted in South Africa, Thailand, and Pakistan.
• Examination of how DOT was operationalized within each study.
• Assessment of study designs for accounting for additional interventions alongside DOT.

Main Results:

• Conflicting results were observed across the three studies evaluating DOT's effect on TB treatment completion.
• Methodological limitations were identified, including inconsistencies in DOT operationalization and failure to account for co-interventions.
• The validity of the measures used to assess DOT's effectiveness in these studies is questioned.

Conclusions:

• The effectiveness of Directly Observed Therapy (DOT) for tuberculosis (TB) treatment completion is not definitively established by the reviewed studies.
• Methodological inconsistencies in study designs and implementation limit the generalizability of findings.
• Addressing the challenge of TB treatment completion likely requires multifaceted strategies beyond a single intervention.